Surrozen (SRZN) Capital Expenditures (2020 - 2026)
Surrozen's Capital Expenditures came in at $19,000 for Q2 2026, up 5.6% from $18,000 a year earlier but down 84.2% from the prior quarter.
Powered by 
Analysis
Surrozen (SRZN) Capital Expenditures (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Surrozen reported Capital Expenditures of $374,000, up 484.4% year-over-year; for FY2025, it was $280,000, up 976.9% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -20.4% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $26,000 in FY2024 (-93.5%), $398,000 in FY2023 (-45.3%), $728,000 in FY2022 (-42.6%) and $1.27 million in FY2021 (+45.2%).
- The five-year range for quarterly Capital Expenditures is $7,000 (Q1 2024) to $541,000 (Q3 2021).
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2026 (growth of 344.4%), and the weakest in Q1 2024 (a decline of 97.8%).
- Business Quant data shows SRZN's Capital Expenditures at $120,000 (Q1 2026), $211,000 (Q4 2025) and $24,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Surrozen | 375.89 Mn | 375.89 Mn | - | 19,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,000.00 |
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 211,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Jun 30, 2023 | 83,000.00 |
| Mar 31, 2023 | 315,000.00 |
| Dec 31, 2022 | 148,000.00 |
| Sep 30, 2022 | 145,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 412,000.00 |
| Dec 31, 2021 | 324,000.00 |
| Sep 30, 2021 | 541,000.00 |
| Jun 30, 2021 | 61,000.00 |
| Mar 31, 2021 | 343,000.00 |
| Dec 31, 2020 | 460,000.00 |
API Access
Surrozen Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SRZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SRZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SRZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();